A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin Lymphoma (NHL)
Sponsor: Eli Lilly and Company
This PHASE1/PHASE2 trial investigates B-cell Lymphoma and Chronic Lymphocytic Leukemia and is currently completed. Eli Lilly and Company leads this study, which shows 25 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
25 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE1/PHASE2
Status: Active Not Recruiting → Completed
-
Oct 2025 — Feb 2026 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Jul 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
May 2025 — Jul 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
▶ Show 20 earlier versions
-
Nov 2024 — May 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2023 — Apr 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Mar 2023 — Apr 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2022 — Mar 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2022 — Sep 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2021 — Feb 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE1_PHASE2
-
May 2021 — Sep 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2020 — Nov 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2019 — Apr 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2019 — Nov 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2019 — Jun 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Dec 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Eli Lilly and Company
- Loxo Oncology, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .